I see the future and the future is bright indeed.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$IPNFF Imagination Park Entertainment, this literally could be the next Universal Studios or Lions Gate in the making. If you don't believe me feel free to go to their website and look at their latest news releases, it absolutely mind blowing. Links Below. Cheers
http://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aIP-2448319&symbol=IP®ion=C
http://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aIP-2450492&symbol=IP®ion=C
CHINA'S LARGEST MEDIA PLATFORM SIGNS HISTORIC AGREEMENT TO FUND IMAGINATION PARK FILMS
IMAGINATION PARK ANNOUNCES EXCLUSIVE DEAL WITH MICHAEL BISPING, UFC MIDDLEWEIGHT CHAMPION OF THE WORLD, FOR PRODUCTION OF A NEW VIRTUAL REALITY SERIES
http://imaginationpark.com/
This is just the beginning IMHO, every week the New Releases just keep getting bigger and bigger. Here's a chart of where the Virtual Reality business is headed as far as potential Future Revenues.
http://static1.businessinsider.com/image/550b4b2069bedd206c9c3e2b-1200-900/bii-sai-cotd-vr-forecast.png
AFI Installing Cannabis Vertical Growing System
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 27, 2017) - Affinor Growers (CSE:AFI)(CSE:AFI.CN)(OTCQB:RSSFF)(FRANKFURT:1AF) ("Affinor" or the "Corporation), is pleased to announce it has shipped and installed a vertical growing system to Mission BC. The four level automated tower will allow Affinor Growers to further develop the technology under commercial conditions and demonstrate capabilities for mass low cost, high quality production of medical cannabis.
The tower will be planted with cannabis in March 2017 and will hold 256 plants in a little over 100 square feet. The purpose of this installation is to grow medical marijuana and to confirm production yields and the viability of the technology with cannabis plants. As a technology seller of vertical growing systems, the installation and growth trial allows Affinor to expand into a different plant sector and demonstrate the diversity of the equipment. The modular stainless system is ideal for highly controlled pharmaceutical growing standards as set up by Health Canada to produce medical cannabis.
The medical cannabis grower, Sam Mellace, located in Mission BC has been cultivating marijuana and marijuana products for several years. This is an opportunity to grow medical cannabis and prove Affinor's technology for both smaller personal medical use and large scale commercial applications. Under the agreement, Affinor will supply a vertical growing tower in return for obtaining the growing data and results, including crop models, yields and productivity.
Affinor will be one of few companies actively testing medical cannabis with vertical growing systems. When Affinor ships another tower to a operation in Kelowna BC, we will have multiple towers trialing cannabis under different commercial conditions ensuring a robust application for future sales throughout North America.
Jarrett Malnarick, CEO, comments, "This is our first steps in achieving our long term goal of selling our equipment for small medical marijuana use and large scale commercial production. We are excited to provide Mr. Mellace our growing technology in order to validate various operational assumptions and production yields. The data and results gained from this initial trial will help create future crop models and determine equipment requirements for future customers."
About Affinor Growers Inc.
Affinor Growers is a publicly traded company on the Canadian Securities Exchange under the symbol ("AFI"). Affinor is focused on growing high quality crops such as romaine lettuce, spinach, strawberries using its vertical farming techniques. Affinor is committed to becoming a pre-eminent supplier and grower, using exclusive vertical farming techniques.
On Behalf of the Board of Directors
AFFINOR GROWERS INC.
Jarrett Malnarick, President & CEO
Read more at http://www.stockhouse.com/news/press-releases/2017/02/27/affinor-growers-installs-vertical-farming-system-for-medical-cannabis-in#V6zXhSmSj4Eh4xSd.99
Read more at http://www.stockhouse.com/companies/bullboard/c.n/namaste-technologies-inc?postid=25899062#yoibPPlrRIA2zZ2m.99
AFI Installing Cannabis Vertical Growing System
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 27, 2017) - Affinor Growers (CSE:AFI)(CSE:AFI.CN)(OTCQB:RSSFF)(FRANKFURT:1AF) ("Affinor" or the "Corporation), is pleased to announce it has shipped and installed a vertical growing system to Mission BC. The four level automated tower will allow Affinor Growers to further develop the technology under commercial conditions and demonstrate capabilities for mass low cost, high quality production of medical cannabis.
The tower will be planted with cannabis in March 2017 and will hold 256 plants in a little over 100 square feet. The purpose of this installation is to grow medical marijuana and to confirm production yields and the viability of the technology with cannabis plants. As a technology seller of vertical growing systems, the installation and growth trial allows Affinor to expand into a different plant sector and demonstrate the diversity of the equipment. The modular stainless system is ideal for highly controlled pharmaceutical growing standards as set up by Health Canada to produce medical cannabis.
The medical cannabis grower, Sam Mellace, located in Mission BC has been cultivating marijuana and marijuana products for several years. This is an opportunity to grow medical cannabis and prove Affinor's technology for both smaller personal medical use and large scale commercial applications. Under the agreement, Affinor will supply a vertical growing tower in return for obtaining the growing data and results, including crop models, yields and productivity.
Affinor will be one of few companies actively testing medical cannabis with vertical growing systems. When Affinor ships another tower to a operation in Kelowna BC, we will have multiple towers trialing cannabis under different commercial conditions ensuring a robust application for future sales throughout North America.
Jarrett Malnarick, CEO, comments, "This is our first steps in achieving our long term goal of selling our equipment for small medical marijuana use and large scale commercial production. We are excited to provide Mr. Mellace our growing technology in order to validate various operational assumptions and production yields. The data and results gained from this initial trial will help create future crop models and determine equipment requirements for future customers."
About Affinor Growers Inc.
Affinor Growers is a publicly traded company on the Canadian Securities Exchange under the symbol ("AFI"). Affinor is focused on growing high quality crops such as romaine lettuce, spinach, strawberries using its vertical farming techniques. Affinor is committed to becoming a pre-eminent supplier and grower, using exclusive vertical farming techniques.
On Behalf of the Board of Directors
AFFINOR GROWERS INC.
Jarrett Malnarick, President & CEO
Read more at http://www.stockhouse.com/news/press-releases/2017/02/27/affinor-growers-installs-vertical-farming-system-for-medical-cannabis-in#V6zXhSmSj4Eh4xSd.99
Read more at http://www.stockhouse.com/companies/bullboard/c.n/namaste-technologies-inc?postid=25899062#yoibPPlrRIA2zZ2m.99
In a move that appears to be in-line with the company’s strategy to develop products for testing and identifying cannabinoid isolates for targeted therapeutic purposes, Vinergy Resources (VIN.CN: CSE) (VNNYF: OTC) signed a binding letter of intent to acquire 65% of Biolennia Laboratories.
The company’s lab operates out of a secure premise in Toronto alongside Micrylium, which manufactures products registered under licensure from various agencies.
Under the terms of the acquisition, Vinergy will acquire 65% of Biolennia for $260,000 CAD and 150,000 shares of Vinergy at the time the agreement is signed. The acquisition is expected to close during the first quarter and we see several synergy opportunities between the two companies.
What Does and Will Biolennia Do?
Biolennia is a specialty development laboratory with expertise in microbiology and chemistry. The lab currently provides testing, R&D and quality control services for Health Canada registered and approved industrial disinfectants and other consumer products on behalf of Micrlylium.
The lab is in the process of applying for a Dealer’s License from Health Canada and the issuance of this license will be a milestone for the company since it would be allowed to process cannabis for R&D purposes.
Biolennia will provide a host of drug testing services to support MJ BioPharma’s product line, product formulation, extraction facilities, systems design, and development of standard-operating-procedures (SOPs).
Biolennia has in-house expertise when it comes to the methods accepted by Health Canada as well as the FDA for determining the purity and quality of many of the materials and methods used in validating cannabis and or testing cannabis products.
Vinergy Resources/MJ BioPharma to Acquire 65% of Health Canada and FDA Licensed Laboratory to Pursue Drug Testing and Dosage of CBDs, THC and Terpenes
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb 22, 2017) - Vinergy Resources Ltd. ("Vinergy" or the "Company") (CSE:VIN)(OTCQB:VNNYF) in conjunction with its proposed acquisition of MJ BioPharma (announced December 14, 2016) is pleased to announce that, as a part of the Company's strategy to develop products that test and identify specific cannabinoid isolates for targeted therapeutic purposes it has signed a binding Letter of Intent ("LOI") to acquire 65% of Biolennia Laboratories Inc. (the "Laboratory").
Biolennia will provide a host of drug testing services to support MJ BioPharma's product line and provide research and development (R&D), product formulation, extraction facilities, systems design and develop standard-operating-procedures (SOPs).
The lab is currently in the process of applying for a Dealer's License from Health Canada. Once issued the license will allow the Company to process cultivated cannabis (extracts and/or derivatives) for R&D purposes.
Biolennia was founded in 2001 by Dean Swift as the internal R&D and quality testing laboratory to support Micrylium Laboratories Inc. ("Micrylium"). In 2002 it upgraded to a full active ingredient and microbial testing laboratory for several Health Canada approved products. Biolennia is a specialty development laboratory with expertise in Microbiology (bacteria, fungi, viruses), Chemistry (proteins, enzymes, drug testing, material science and analytics). The Laboratory currently provides testing, R&D and quality control for a proprietary line of Health Canada registered and approved industrial disinfectants and other consumer products on behalf of Micrlylium.
Biolennia has in-house expertise in methods accepted by Health Canada and the Federal Drug Administration (FDA) for determining purity and quality of many of the materials and methods used in validating cannabis and or testing cannabis products. Biolennia brings a highly talented team of Microbiologists who are familiar with testing high purity water, ethanol, ethyl acetate, propylene glycol, xylitol, glycerine, propandiaol, d-limonene, myrcene, and beta caryophelline.
The lab operates from a secure premises in Toronto, Ontario (Canada) alongside Micrylium which manufactures products registered under licensure from various agencies including: CE, FDA, EPA, Health Canada, Swiss BAG, and German VAH. MJ BioPharma will provide the proprietary line of disinfectant products, globally to the cannabis industry to ensure improved hygiene for cultivation facilities, nutrient hoses, labs, extraction systems, dry utensils and edibles manufacturing spaces.
Under the terms of the acquisition Vinergy/MJ BioPharma will acquire 65% of Biolennia for CAD $260,000 and 150,000 shares of Vinergy at the time the definitive agreement is signed. The Company expects to close on the acquisition in Q1-2017.
"This is a fantastic acquisition for us and supports our entire product line and R&D initiatives moving forward. Our technical expertise in drug testing, extractions, and formulas containing CBD, Terpene, THC and other botanicals is continually being furthered. We have a remarkable team. We feel strongly that science based products formulated from extracts and derivatives that are properly dosed and manufactured in GMP environments to ensure consistency and safety for all customers whether they be recreational or medical users, is the future of the cannabis industry," MJ BioPharma CEO Kent A. Deuters.
Read more at http://www.stockhouse.com/companies/bullboard/c.vin/vinergy-resources-ltd?postid=25876041#DegoD6hkciD7BT7h.99
Thanks for sharing MrCheap.
Canada’s Vinergy Resources (VNNYF) is also taking active steps toward growing its product portfolio to become a key player in the global cannabis industry. Late last year, the company announced plans to acquire MJ BioPharma, a cannabis technology company focused on the development of new extractions and formulations for medicinal and recreational use, both domestically and internationally. In addition to the MJ BioPharma acquisition, Vinergy has also initiated the acquisition of up to 51 percent of a large European plant with an extensive catalogue of more than 2,000 cannabis and hemp strains. The name of the European company has not yet been disclosed.
It seems people are searching for peace, tranquility, and a sense of overall well being these days. There is so much anxiety in combination with the instability of the the economy, government, the weather, and life in general is overwhelming for many of us. The pursuit is always to find that natural high, whether from yoga, meditation, running, or anything that gets the blood moving and oxygen flowing.
Getting high on life can be a wonderful experience. For many, the high is achieved through the use of psychoactive substances. Ever since the 2016 election, there is a lot of hype going around the states that have passed the use of cannabis, since the legalization of it is becoming more broad. Among the cannabinoids in marijuana, the main psychoactive compound, THC, often transcends the other one. Cannabidiol can provide a natural anti-anxiety, antipsychotic, and anti-epileptic effect.
Cannabidiol, or CBD, is used by itself, with no high. However, when combined with THC, the relaxing effect is claimed to fight off any feelings of paranoia that can sometimes be felt under the influence. There are a few digital gateways that “explore the evolving world of cannabis products and services” with a target on marijuana culture. Many others are cropping up for consumers seeking more in-depth information pertaining to the rapidly growing recreational and medical marijuana industry.
Smoking is the most popular way to ingest the substance and offers the fastest reaction. Vaporizing (vaping) has become more popular since a vaporizer creates vapor, there is a reduced risk of choking on the drug upon inhaling. It offers a smoother delivery. The most attractive and pleasing for many are the edibles, or “Medibles.” The creative delivery of cannabis-infused food and beverages claim to provide a longer lasting effect.
Hope everyone had a great long weekend, i'm excited for $VNNYF this week and the whole sector in general.
Looks like Mr.Simon has relationships in place that could be extremely beneficial for $VNNYF moving forward.
Mr. Simon has held various management positions in quality assurance (QA) and regulatory affairs, and has worked as a consultant supporting clients in the medical device, pharmaceutical, biotechnology and natural health product industries since 2004. He has been directly involved in U.S. Food and Drug Administration (FDA) and Health Canada audits of medical device manufacturers, drug manufacturers, testing facilities and clinical sites. He has experience with submissions to the FDA and Health Canada
Remember we are still in the early day on $VNNYF everyone. Canada is the epicenter of the world right now when it comes to this sector.
$VNNYF has massive Potential to say the least my friend. GWPH has been around for a while so they obviously have a head start but $VNNYF a few years from now could become a major player in the sector.
This is massive news, CBD Strips are the way of the future my friends. Exciting morning to say the least.
VINERGY RESOURCES/MJ BIOPHARMA ANNOUNCES BREAKTHROUGH IN ORAL CANNABINOID STRIP AND TIME RELEASE CAPSULE TECHNOLOGIES
VANCOUVER, BRITISH COLUMBIA–(Marketwired – Feb. 14, 2017) - Vinergy Resources Ltd. (“Vinergy” or the “Company”)(CSE:VIN)(CSE:VIN.CN)(OTCQB:VNNYF) in conjunction with its proposed acquisition of MJ Biopharma (announced December 14, 2016) is pleased to announce a major breakthrough while conducting research and development on oral cannabinoid complex (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Cannabinol (CBN) and Terpenes) delivery strips and controlled time release capsule technology. This novel approach will be the basis for several products where water or saliva is the catalyst used to activate the carrier for delivery and absorption of the cannabinoid complex into the body.
This unique approach forms the basis for a fundamentally new technology and product category. The technology is called “BURST” due to its incredibly fast action and ability to enhance the body’s absorption of various medicinal ingredients contained in the Company’s products. The BURST system is built on natural botanical polymers delivering specially processed high purity cannabinoid complexes.
The unique system for cannabinoid activation maintains the natural balance of THC, CBD, CBN and terpenes while preserving the maximum therapeutic effect and potentially delivering it to the body faster than any currently available delivery method.
The patent pending technology allows for a more complete palatable drug delivery system that is effective and enhances the patient or user experience while intensifying flavour.
“This is a great breakthrough for us and the product line we have planned. The technology can also be utilized in our time release capsules which of course will have a slower absorption rate. We think time release capsules are extremely important as they help bridge the gap in terms of familiarity with many patients who want to switch from synthetic drugs to a natural product as a way to reduce side effects and drug,” said Mr. Kent Deuters, CEO of MJ Biopharma. “We look forward to providing additional updates in the coming weeks,” added Mr. Deuters.
The Hemp Business Journal estimates the total U.S. CBD market will grow to $2.1 billion in consumer sales by 2020.
Read more at http://www.stockhouse.com/companies/bullboard/c.vin/vinergy-resources-ltd?postid=25841544#a7ffMgfqueTmjvBQ.99
On any type of positive news or updates and we will see $VNNYF move past its current 52 week high IMHO. The consolidation has been beautiful over the last several trading days, it looks as though $VNNYF has finally found its bottom.
Looks like $VNNYF is slowly moving back into the green today.
I'm expecting a big week ahead for $VNNYF, the stock pulled back in Canada today but was bought up in droves. Any type of positive news or updates and this stock will be off to the races IMHO.
Annual sales in excess of CAD $14,000,000 and adjusted EBITDA of over CAD $2,000,000
LP's in Canada are currently valued at 20-25 times revenue
Using 20:
20x ($14m x 51%) = $140 million
Using 25:
25x (414m x 51%) = $178 million
Thus at 36m shares VIN should be trading north of $3 once the deal closes.
Again i just used current acquisition historical sales
* Other deals could happen
* VIN is looking to go global
* VIN is looking to work with large growers and provide access for them to a comprehensive catalogue of cannabis strains.
* The company will also aim to in- license and joint venture on best in class technologies and products for both the medicinal and recreational markets - domestically and internationally.
Thanks for sharing 136, this email sounds very positive. $VNNYF
Thank you for the email and we are glad to have you on board.
Unfortunately, we cannot reveal the name of the "target" until it is a definitive agreement. As stated in the press release, it is currently an LOI to acquire 51% of the target company.
The name will be revealed once a definitive agreement is made, which we are expecting to be closed before the end of Q1 - in addition, this will allow us to give more details overall about the acquisition and the "target" company itself as well at that time.
If you like, I can add you to our mailing list to be updated as soon as new information is released regarding Vinergy Resources Ltd.
Thank you for your continuous support.
I actually do believe $VNNYF may surprise you in, even in the near future. If and when they announce the closing of the 51 percent stake with the $14,000,000 Grower then you will see the market go absolutely crazy IMHO.
Normally I would agree with you but from what I have been hearing from a lot of people is that this deal is far from being done.
That's just my 2 bits but i'm very confident with this company moving forward.
We've had healthy consolidation over the last 2 days on $VNNYF, this is normal on any stock that's had a big move. If and when $VNNYF puts out any type of positive news flow this will move up quickly and surpass its last high easily IMHO.
I look at days like today as an opportunity, Canopy Growth and all the other massive Medical Marijuana companies all had periods of consolidation before they all ran into the Multiple $$$ Patience will be key. Days like today you get stock out of shaky hands which is a good thing.
I look at today as an opportunity my friend!
This is healthy consolidation today, which is very typical of any stock that's had a healthy move. Any type of positive news and this stock will move well past the current 52 week high IMHO.
Its time to put $VNNYF on your watch list everyone, here's some info on their latest transaction. $VNNYF
$VNNYF Vinergy Resources/MJ BioPharma to Acquire Majority Stake in Multinational Plant Breeder with CAD $14,000,000 in Annual Sales
TheNewswire.ca - Thu Feb 02, 2:22PM CST
(via TheNewswire)
VANCOUVER, BC / TheNewswire / February 02, 2017 - Vinergy Resources Ltd. ("Vinergy" or the "Company")(CNSX:VIN.CN)(OTCQB:VNNYF) in conjunction with its proposed acquisition of MJ Biopharma (announced December 14, 2016) is pleased to announce that it has signed a Letter of Intent (LOI) to acquire up to 51% of a European multinational plant breeding company ("Target"). The Target has audited annual sales in excess of CAD $14,000,000 and adjusted EBITDA of over CAD $2,000,000.
This development is a major step forward in establishing Vinergy as a leader in the global cannabis industry. The Target is a leading developer of plants and plant genetics and has been providing global customers with various commercial agriculture services for over 25 years. In 2016 they shipped over 35,000,000 plant products to the global marketplace. As part of the acquisition, Vinergy now has access to an extensive catalogue of over 2000 hemp and cannabis strains with the ability to supply those strains to customers globally.
Together with Vinergy, the Target has the capacity to expand rapidly into the hemp, cannabis and cannabinoid (CBD) sectors across Europe. "CBD is revolutionizing the global chronic pain management market and we have determined we can utilize our first mover advantage to take a leading market position in multiple countries," said Mr. Kent Deuters, CEO of MJ Biopharma. "Given the current marketplace dynamics, existing customer base and technology we now have access to; we plan to immediately roll out several new hemp and CBD initiatives. Additionally, it's important for our investors to know that we are diversified and not totally dependent on the cannabis space but have multiple complimentary revenue verticals."
The global CBD market is experiencing significant growth: Europe's market potential for CBDs is estimated to be EUR2 billion as a treatment for chronic diseases, according to a new report by Nova-Institute and HempConsult (both of Germany). The reports reviewed the market for non-psychotropic CBD which is increasingly in demand as a food supplement and pharmaceutical. The Hemp Business Journal estimates the total U.S. CBD market will grow to a $2.1 billion market in consumer sales by 2020 with $450 million of those sales coming from hemp-based sources
$VNNYF is off to the races this week!
$VNNYF Vinergy Resources/MJ BioPharma to Acquire Majority Stake in Multinational Plant Breeder with CAD $14,000,000 in Annual Sales
TheNewswire.ca - Thu Feb 02, 2:22PM CST
(via TheNewswire)
VANCOUVER, BC / TheNewswire / February 02, 2017 - Vinergy Resources Ltd. ("Vinergy" or the "Company")(CNSX:VIN.CN)(OTCQB:VNNYF) in conjunction with its proposed acquisition of MJ Biopharma (announced December 14, 2016) is pleased to announce that it has signed a Letter of Intent (LOI) to acquire up to 51% of a European multinational plant breeding company ("Target"). The Target has audited annual sales in excess of CAD $14,000,000 and adjusted EBITDA of over CAD $2,000,000.
This development is a major step forward in establishing Vinergy as a leader in the global cannabis industry. The Target is a leading developer of plants and plant genetics and has been providing global customers with various commercial agriculture services for over 25 years. In 2016 they shipped over 35,000,000 plant products to the global marketplace. As part of the acquisition, Vinergy now has access to an extensive catalogue of over 2000 hemp and cannabis strains with the ability to supply those strains to customers globally.
Together with Vinergy, the Target has the capacity to expand rapidly into the hemp, cannabis and cannabinoid (CBD) sectors across Europe. "CBD is revolutionizing the global chronic pain management market and we have determined we can utilize our first mover advantage to take a leading market position in multiple countries," said Mr. Kent Deuters, CEO of MJ Biopharma. "Given the current marketplace dynamics, existing customer base and technology we now have access to; we plan to immediately roll out several new hemp and CBD initiatives. Additionally, it's important for our investors to know that we are diversified and not totally dependent on the cannabis space but have multiple complimentary revenue verticals."
The global CBD market is experiencing significant growth: Europe's market potential for CBDs is estimated to be EUR2 billion as a treatment for chronic diseases, according to a new report by Nova-Institute and HempConsult (both of Germany). The reports reviewed the market for non-psychotropic CBD which is increasingly in demand as a food supplement and pharmaceutical. The Hemp Business Journal estimates the total U.S. CBD market will grow to a $2.1 billion market in consumer sales by 2020 with $450 million of those sales coming from hemp-based sources
$VNNYF has been trending all day and this evening on Social Media today, I've been hearing but positive feedback.
51% Stake in a $14 Million dollar operation is a hell of a way to start a company out of the gate!
Expecting a great week ahead for $VNNYF, i'm starting to see the Symbol
NEW OTC MJ STOCK: $VNNYF .84 up 8% close Fri. which was only it's 3rd day of trading publicly!! Probably more than 99.999% of the investing/trading public have NEVER HEARD OF VNNYF!!! Use your imagination to guess how this stock could run in a huge way over the next few weeks/months maybe! Plus there was very exciting acquisition news on the company out Thursday which is a must read...all imho. Vinergy Resources/MJ BioPharma to Acquire Majority Stake in Multinational Plant Breeder with CAD $14,000,000 in Annual Sales.
$VNNYF
This is from the MOMO Board from Tuna. Looks like people are finally starting to wake up on the potential for this company moving forward!! Lets go $VNNYF!!
NEW OTC MJ STOCK: VNNYF .84 up 8% close Fri. which was only it's 3rd day of trading publicly!! Probably more than 99.999% of the investing/trading public have NEVER HEARD OF VNNYF!!! Use your imagination to guess how this stock could run in a huge way over the next few weeks/months maybe! Plus there was very exciting acquisition news on the company out Thursday which is a must read...all imho. Vinergy Resources/MJ BioPharma to Acquire Majority Stake in Multinational Plant Breeder with CAD $14,000,000 in Annual Sales.
$VNNYF
Thanks for the Info Tuna on $VNNYF!
NEW OTC MJ STOCK: VNNYF .84 up 8% close Fri. which was only it's 3rd day of trading publicly!! Probably more than 99.999% of the investing/trading public have NEVER HEARD OF VNNYF!!! Use your imagination to guess how this stock could run in a huge way over the next few weeks/months maybe! Plus there was very exciting acquisition news on the company out Thursday which is a must read...all imho. Vinergy Resources/MJ BioPharma to Acquire Majority Stake in Multinational Plant Breeder with CAD $14,000,000 in Annual Sales.
$VNNYF
Hi Clay, I just thought I'd bring ($VNNYF) to your attention.
Symbol $VNNYF
I'm even more optimistic about the Future of $VNNYF after reading this lithiumjr, thanks for sharing!
$3+ coming, Here's why....
Note ** This is all based on just this 1 current deal:
Annual sales in excess of CAD $14,000,000 and adjusted EBITDA of over CAD $2,000,000
LP's in Canada are currently valued at 20-25 times revenue
Using 20:
20x ($14m x 51%) = $140 million
Using 25:
25x (414m x 51%) = $178 million
Thus at 36m shares VIN should be trading north of $3 once the deal closes.
Again i just used current acquisition historical sales
* Other deals could happen
* VIN is looking to go global
* VIN is looking to work with large growers and provide access for them to a comprehensive catalogue of cannabis strains.
* The company will also aim to in- license and joint venture on best in class technologies and products for both the medicinal and recreational markets - domestically and internationally.
So honestly....$3 is the bare minimum for VIN...
And who knows...one of the big 5 (WEED, APH, ACB, OGI, EMC) could be interested in our internatioal oil patent and now, 2000 IP canabis strains and Euro / Global market reach...
I'm Very very excited for next week, $VNNYF actually closed at $1.11 Canadian.
VINERGY RESOURCES/MJ BIOPHARMA TO ACQUIRE MAJORITY STAKE IN MULTINATIONAL PLANT BREEDER WITH CAD$14,000,000 IN ANNUAL SALES
Vinergy Resources Ltd. in conjunction with its proposed acquisition of MJ Biopharma (announced Dec. 14, 2016) has signed a letter of intent to acquire up to 51 per cent of a European multinational plant-breeding company (target). The target has audited annual sales in excess of $14-million and adjusted earnings before interest, taxes, depreciation and amortization of over $2-million.
This development is a major step forward in establishing Vinergy as a leader in the global cannabis industry. The target is a leading developer of plants and plant genetics and has been providing global customers with various commercial agriculture services for over 25 years. In 2016, it shipped over 35 million plant products to the global marketplace. As part of the acquisition, Vinergy now has access to an extensive catalogue of over 2,000 hemp and cannabis strains with the ability to supply those strains to customers globally.
Together with Vinergy, the target has the capacity to expand rapidly into the hemp, cannabis and cannabinoid (CBD) sectors across Europe.
"CBD is revolutionizing the global chronic-pain management market, and we have determined we can utilize our first-mover advantage to take a leading market position in multiple countries," said Kent Deuters, chief executive officer of MJ Biopharma. "Given the current marketplace dynamics, existing customer base and technology we now have access to, we plan to immediately roll out several new hemp and CBD initiatives. Additionally, it's important for our investors to know that we are diversified and not totally dependent on the cannabis space but have multiple complementary revenue verticals."
The global CBD market is experiencing significant growth: Europe's market potential for CBDs is estimated to be two billion as a treatment for chronic diseases, according to a new report by Nova Institute and Hemp Consult (both of Germany). The reports reviewed the market for non-psychotropic CBD, which is increasingly in demand as a food supplement and pharmaceutical. The Hemp Business Journal estimates the total U.S. CBD market will increase to a $2.1-billion market in consumer sales by 2020 with $450-million of those sales coming from hemp-based sources.
"Our goal has always been to control every step of the production process from genetics, right through to extraction, ensuring only the highest-quality extracts are used in the formulation of our strips, time-release capsules and other products currently under development for the medical and recreational cannabis space," added Mr. Deuters.
The company will aim to work with large growers and provide access for them to a comprehensive catalogue of cannabis strains.
$VNNYF now a $1.10 Canadian now. Offers are being ripped out as we speak.
This was posted on another forum, thought people might find this interesting.
Look at AXIM Biotechologies
Oct 24tgh 2016 AXIM was trading at 40 cents....3 montsh later Jan 12th 2017, $19.80
They are in the cannabinoid delivery system (As is VIN)...
They make no money and have no money:
Earning a current market cap value of $772M, AXIM has $870k in cash on the books, which stands against about $4.1M total current liabilities. AXIM is effectively pre-revenue at this point.
About AXIM
AXIM® Biotechnologies, Inc. (OTC:AXIM) focuses on the research, development and production of cannabis-based pharmaceutical, nutraceutical and cosmetic products.
AXIM Biotechnologies Inc. has made a name for itself by creating unique delivery systems for cannabinoids. For example, the company's cannabinoid-infused chewing gum provides extended release for conditions like chronic pain, while its cannabinoid-containing toothpaste is designed to treat infection and gum disease. The company is working toward full FDA/EMA registration for one of its products as early as 2018 with the rest coming soon after.
======
VIN
About MJ Biopharma
MJ Biopharma is a cannabis technology company with a team of highly experienced business and medical professionals, biochemists and researchers. The company is currently focused on the following areas of interest:
Manufacturing breath strips;
Time-release capsules;
Extract oils;
Food products, and infused juices, teas, coffee and extract drinks;
Pharmaceutical-grade delivery systems.
MJ Biopharma's expertise lies in its extracts and custom formulations. The company will also aim to in-license and joint venture on best-in-class technologies and products for both the medicinal and recreational markets -- domestically and internationally.
$1.11 Now VNNYF is starting to break out here.
$1.10 now
VINNYF last trade at $1.09 up in Canada.
Vinergy Resources (VIN.C) buys their own ‘green organic Dutchman’.
New cannabis player Vinergy Resources (VIN.C) has announced a surprise deal to acquire a potential 51% stake in an established a European growhouse, nursery, and tissue culture player with decades of history in the business.
The target company that already does $14 million annually in audited revenue selling plants across Europe and beyond, is looking to expand into marijuana cultivation to fill a fast growing demand in nations such as Germany and Switzerland.
The company has shipped 35 million indoor, outdoor and edible plants globally from its lab and nursery headquarters.
Vinergy is a recent entrant into the Canadian public company cannabis space, with some of the technology coming from a family-owned, hard science background lab, while this latest acquisition is an established, mass agriculture business that currently sends indoor and outdoor plants to customers around the world, with a thriving tissue culture business already in operation within the potato trade.
The deal is a concerted push into the international space for Vinergy, where it sees long term growth potential in both the agricultural space in general, and more specifically across the cannabis sector.
The company they’re buying into has an FDA-certified laboratory with an R&D facility, rooting station, and weening facilities in in addition to a low cost, high efficiency lab.
The target’s plan is to make a global push into the tissue culturing industry, where it sees much potential in a business currently served by third world players developing low grade products. To that end, it began operations in the potato industry, using tissue culturing to cut turnaround time for crops by as much as 2/3.
Currently, the company does 65% (€ 6.2 million annually) of its business in indoor plants, 20% in outdoors plants, and 15% in seed potatoes through its tissue culturing set-up.
Existing and potential customers include large retail players such as Home Depot, Wal-Mart, Costco, and similar sized European chains, as well as large scale agricultural operations.
The marijuana push within the company comes with an existing cannabis license, an export license, and strong interest from the growing EU market for cannabis and CBDs.
Money from the sale to Vinergy will reportedly go towards building out that aspect of the business and accelerating the cannabis product development side.
For Vinergy, the deal looks easy to finance, given current market conditions, and opens a significant market to their products, licensing deals, and technology. At worst, they’re paying for a successful agricultural set-up that has market share, revenue, and is profitable. At best, they get to turn on the weed side of the business, while the tissue culturing operation shifts gears into the cannabis market, bringing a high ceiling of potential revenues going forward. The opportunity to move their own products into Europe through an existing supply chain is a big deal.
Vinergy recently announced it had commenced trading on the OTCQB.
Read more at http://www.stockhouse.com/companies/bullboard/c.vin/vinergy-resources-ltd?postid=25790954#4xVbwtcU1ffdSmDD.99
New Cantor Fitzgerald Research Report, stating a $3.30 Canadian Year Price Target for $BRIZF. Worth the read.
http://www.cantorcanada.com/pdfFiles/20160518BRI.pdf